Clinicians and policymakers rely on the U.S. Preventive Services Task Force (USPSTF) for reliable and accurate information. In their recent update on USPSTF methods, Sawaya and colleagues (1) described USPSTF criteria for constructing and evaluating an indirect "chain of evidence" for the effectiveness of a preventive service when direct evidence from 1 or more randomized effectiveness studies is unavailable. They also stated that their methods for making evidence-based recommendations would continue to evolve. I have a comment about the chain-of-evidence approach and suggest the next step in the evolution of the recommendation process.
IN RESPONSE:
We appreciate Dr. Hahn's thoughtful consideration of the potential distinctions between and within USPSTF recommendation grade letters and the role of certainty in arriving at the recommendation grade.
His suggestion that the USPSTF never assign any grade higher than B to a recommendation based on the chain-of-evidence approach (in fact, his proposal would create a new B-minus category for any positive recommendation made on the basis of indirect evidence) implies that only evidence from randomized trials merits a judgment that "certainty of net benefit is high." In at least some cases, randomized trials of preventive services are not necessary to ascertain high net benefit. Support for smoking cessation counseling in primary care is, for example, an A recommendation with a high certainty of net benefit. It is based on the chain-of-evidence approach: counseling results in smoking cessation, smoking cessation prevents lung cancer, and prevention of lung cancer increases longevity.
The USPSTF also recognizes that the randomized-trialas-evidence standard is unattainable for many clinical preventive services. It is not feasible, for example, to conduct a randomized trial of the effect of HIV screening in pregnant women on childhood morbidity and mortality for ethical reasons and because the sample size and cost of such a trial would be prohibitive. The USPSTF rated its recommendations for universal HIV screening in pregnancy as an A recommendation by using the chain-of-evidence approach: Screening detects HIV infection in the mother, treatment of the mother during pregnancy prevents HIV transmission to the newborn, and prevention of newborn HIV infection prevents HIV morbidity and mortality.
The USPSTF is not indifferent to Dr. Hahn's concern about the use of surrogate outcomes instead of patient-oriented outcomes as the desirable basis for recommending interventions, including preventive interventions. If randomized trials are feasible and necessary to draw a conclusion that has high certainty, they should be conducted, and conclusions about the use of the intervention should be delayed pending the results.
The USPSTF knows that much of its intended audience is unaware of the distinction between grade A and B recommendationsboth are recommended for use in routine practice. As a potential guide to policymakers, those who design quality measurements, or even clinicians who may use the distinction between A and B recommendations for prioritization purposes, the USPSTF will continue to use both and reserve the grade A recommendation for services with the most ironclad evidence, and therefore the highest certainty, about the impact of the service on health outcomes. mendations. In pointing out success stories, the article overlooked one of the largest health care systems in the United States, which covers more than 9 million men, women, and children: the U.S. Department of Defense's Military Health System (MHS) TRICARE health plan. The MHS is vigorously addressing the problems identified in caring for wounded warriors at Walter Reed Army Medical Center and across the system. Looking beyond those military-specific challenges, observers will find a large and complex health care program worthy of further examination.
The MHS is an integrated system of care that covers the health care needs of a diverse population of all ages, including children and dependents of active duty service members. No person within the MHS is denied coverage because of preexisting conditions. In fact, the U.S. military provides health care services that many service members and dependents never had access to before enlistment because they were uninsured or underinsured or lived in rural areas with few providers. For many, the MHS fills a gap in the fragmented U.S. health care system.
The TRICARE plan offers multiple insurance options ranging from a comprehensive, low-or no-fee, HMO-type plan to a traditional, more expensive fee-for-service plan. The TRICARE plan and the MHS currently meet several of the College's recommendations: 1 (universal coverage), 3 (cost savings), 5 (no financial barriers), 6 (personal responsibility), 10 (performance), and 11 (electronic records). These items have been implemented or expanded during the past decade as the number of beneficiaries and the budget required to support them have grown to support current armed conflicts.
The mission of military medicine goes beyond what is expected of most health systems: Our service members must maintain excellent health to reduce death, injuries, and disease during and after military operations. To be successful and achieve excellence, the MHS must care for service members and their families while also efficiently managing U.S. Department of Defense health care costs.
As evidence of successfully meeting our mission, a recent study conducted by RTI International (Brown DS, et al. Morbidity, mortality, and use of preventive health measures among Prime beneficiaries of the Military Health System compared to national and international populations. Final report, October 2007.) showed that TRICARE Prime, our HMO insurance plan, outperformed the overall U.S. population (insured and uninsured) on 6 clinical preventive measures.
We continue to search for ways to improve our quality of care and to strengthen the health of the nation's military families. To accomplish this, we will continue to review the College's recommendations, as well as our internal strategic plans. TO THE EDITOR: With due respect to the extensive effort by the authors of the College's recent position paper (1), I would like to highlight several points of disagreement and disappointment. First, when advocating for a government-run, single-payer system (federal or state), we must decide whether this will resemble the current Medicare or Medicaid system. The latter will obviously lead to most enrollees losing real-time or real-world access to their physicians (similar to how current Medicaid HMOs, while "covering" a large portion of the low-income population, don't have any participating physicians for their members to get care from).
S. Ward Casscells
Second, the paper does not say whether physicians will be forced to participate in this single-payer system and what the implications might be if a large percentage of primary and principal care physicians decide not to participate. This will obviously exacerbate the current access problems.
Third, the most glaring omission is in not addressing the impact of a litigious society, which leads to the practice of defensive medicine. There is no effort to compare the medicolegal systems of the United States with those of the other countries mentioned in other comparisons.
Fourth, the issue of chronic disease management and end-of-life care is addressed only marginally. As we know, a substantial portion of health care cost is in these 2 areas. No mechanism is suggested to help make chronic disease management more effective, such as the use of remote monitoring technology (e-visits); to ensure appropriate reimbursement for such management; or to promote involvement of employers in providing incentives for such management.
Fifth, as a physician, I would have liked to see language saying that payment for services should be at the time of service, with insurance plans or the single payer being legally obligated to reimburse for services rendered to plan members without the option to deny payments. This comes down to simplification of billing and collection procedures by using information technology so that physicians are not forced to use "middlemen," such as clearinghouses, for processing claims. This would reduce the cost of collecting what is legitimately due to a physician. A "smart card" in this situation would be ideal.
Finally, legislation with clear definitions of contractual language between information technology vendors and physicians, with provisions for swift remedies not involving litigation, would substantially increase adoption of information technology in physician practices. This discussion was omitted in the College's position paper, and I hope the College issues a follow-up paper that addresses at least some of these points. data presented. Certainly, we could reach a strong consensus that our current system, despite the superb quality of care available to most Americans, fails to provide the same quality of care to everyone. It is also undeniable that the rapidly growing cost of our system will soon begin to tax our ability to continue to improve and innovate. Reform is necessary.
The College's recommendations for reform, however, ignore one of the key elements driving overuse of technology. Overuse of technology is a complex issue, but fear of liability actions clearly takes a huge toll on most physicians and results in substantial use of medically unnecessary (but legally driven) diagnostic procedures. As physicians, we are partly responsible for the importance of malpractice liability actions in our system because we have not been effective in eliminating low-quality practices and practitioners. Our political system, driven by special interests, is similarly responsible.
The recommendations of the College also ignore the particular consumer psyche of the American patient. All of the systems used for comparison provide less-expensive health care at the cost of decreased access to and quantity of specialty care. In the single-payer systems, delays in care caused by shortages, particularly in technologically advanced care, effectively ration costly therapies. Given the choice, most Americans will opt for immediate access to care, even when it comes with a higher price tag. (This tendency was reflected in Medicare HMO programs initially underestimating the demand and subsequent cost created by new members who were unwilling to see primary care providers for their previously diagnosed problems.) I doubt seriously that Americans will have the same high level of satisfaction as their Canadian counterparts when computed tomography to investigate a new lung nodule and the subsequent bronchoscopy or transthoracic needle biopsy is routinely scheduled with a 3-or 4-week delay. The health outcome of immediate care might not differ, but the level of satisfaction certainly would. Americans may not be able to afford to be "spoiled" for much longer, but changing the U.S. health care culture will take much more than legislation.
The College's position paper also makes a very risky assumption: Single-payer systems are less expensive because they are singlepayer systems. Any system that efficiently rations expensive care will save money. Conversely, single-payer systems that are not structured to limit access to care (Medicare, for instance) can be associated with accelerated growth in costs because of lack of tempering market forces. If our elected officials are responsible for setting health care spending policy, no one will likely have the stomach to own the restrictions necessary to control spending. Certainly that has been our recent experience. A U.S. single-payer system is unlikely to provide redemption.
Each of the problems addressed in this very important position paper warrant immediate and thorough attention and reform. I am unconvinced from the evidence presented that a single-payer system will lead to solutions for any problem except universal access and instead, because of the nature of government, will worsen many of the problems cited. Although the scholarly and respected leadership at the College who endorse a single-payer system may be ready to place the fate of their personal health care in the hands of the same political system and government that created the Centers for Medicare & Medicaid Services, Transportation Security Administration, Internal Revenue Service, U.S. Department of Agriculture, Social Security Administration, and Veterans Administration, I would like to have the option of using some of my own resources to allow me to choose access to a different level or type of health care (without having to leave the country). Although we should guarantee access to care for all Americans, the fact that some may not be able to afford a level of care that I might choose to purchase should not be an argument for denying me this privilege.
Suggesting a single-payer system to solve our health care problems is, in essence, throwing up our hands and admitting that we give up. Single-payer systems will not solve our problems, but merely shift them. Obviously, our political leaders will not or cannot solve the complex problems faced by our health care system. As the professionals responsible for the outcome of each of our patients and anyone who could need care, we need to do better than this. TO THE EDITOR: When comparing the health care system in the United States with the national health plans in other countries, we can learn many lessons about health outcomes and health economics. With no national health plan and an emphasis on market forces, the United States is unprepared for negotiations between government and physicians.
Richard S. Leff, MD
In a national health program, individuals and organizations representing both physicians and patients sit around a negotiating table and hammer out the terms of medical practice. In the United Kingdom, which has a highly centralized system, representatives of the Department of Health-representing society-sit at the table with the British Medical Association, a union to which 80% of practicing physicians belong-representing the medical profession. In Canada, constitutional responsibility for health care rests with the provinces, and each province has its own negotiating table (although the federal government continues to play an important role). Provincial ministers of health represent society, and the provincial medical associations negotiate on behalf of the medical profession. The provincial medical associations function as unions or quasi-unions, with all practicing physicians paying dues. Most issues, including working conditions and the amount and method of remuneration, are negotiated at the provincial level. The federal government, through the Canada Health Act, attempts to ensure reasonable uniformity throughout the country by imposing the conditions that the provincial programs must meet to be eligible for federal funding. Although many stakeholders have an interest, the national negotiations affecting the medical profession are primarily between Health Canada and the Canadian Medical Association, to which 60% of physicians belong.
This situation contrasts with that in the United States. As pointed out by Stevens (1), the United States lacks "concentration of responsibility for universal health insurance at national, state, or local levels, and no single government agency [is] responsible for delegating formal power to medical organizations in relation to organized payment and service systems." With no national health care program, the United States has not needed a nationwide negotiating table or a series of regional ones. It has not needed to decide which Letters of the various professional organizations should represent the profession as a whole. Historically, the American Medical Association has fulfilled this function and has the structure to support the role. However, the small percentage of practicing physicians who belong to the American Medical Association weakens its claim to represent the profession. The primary allegiance of most practitioners is to their specialty or subspecialty associations, who also try to represent their members' interests to legislators and regulators. In the United States, medicine speaks with many voices at a time when common issues are of concern to every practicing physician.
We do not claim that the system of negotiations in the United Kingdom or Canada is ideal. Physicians often do not agree with those negotiating on their behalf; the negotiations are generally asymmetrical, with governments enjoying much stronger bargaining positions; and physician discontent is certainly present. However, everyone knows where the negotiations take place, who the involved parties are, and what is on the agenda. The profession itself has had to develop processes for deciding its position on a variety of issues that stand at the intersection of the profession and society. One can speculate that both medicine and society in the United States have suffered from the lack of a proper forum for discussing these issues. If the United States develops a national health program, it will have to create a negotiating table or a series of regional tables. More than dollars and cents will be on the agenda: equity, social justice, physician autonomy, and many other topics will need to be discussed. Important aspects of the social contract between medicine and society will be renegotiated. If the United States moves toward a national health plan, the medical profession should clarify who represents it and develop some consensus on the very fundamental issues it will soon face. As in so many other areas, the United States can learn from examining the systems in other countries. TO THE EDITOR: The recent position paper by the American College of Physicians (1) was insightful. I think the factual information and most of the recommendations were right on the mark. My only concern is the absence of any mention of physician accountability in the discussion on controlling health care costs. The recommendation to "create incentives to encourage patients to be prudent purchasers" will require changes in current insurance regulations, but this is an absolute necessity. Because that was the only recommendation in the section on cost control, it seems to be a one-sided solution. Patients certainly may create demand, but physicians-through their actionsare a major driver of health care costs. We are the ones who write the orders, prescribe the drugs, and recommend the therapies.
At the recent meeting of the National Quality Forum's National Priorities Partnership, the word "accountability" was frequently used by many of the organizations represented. I would suggest that, as physician organizations, we must assume responsibility for managing health care costs through oversight of our professional colleagues' clinical activity. It was the failure of physician accountability that drove payers to adopt utilization management oversight. That created situations where external groups made coverage decisions that sometimes had negative health consequences. We certainly don't want to return to the days of capitation, with the small practice bearing the risk.
The College can make positive recommendations toward the development of accountability. The first opportunity is through the model of the patient-centered medical home, which is described in the position paper. However, the concept of "accountability" is never addressed. I would suggest that the College include "accountability" as an attribute of the medical home. Accountability structures will promote the concept of the medical home as a legitimate entity that provides improved quality of care as the primary physician assumes greater responsibility. Such efforts will help garner more support among employers.
The College could also look toward the development of voluntary review boards that could work with private and governmental payers at local levels to analyze data and provide peer-level counseling or recommendations. A recent editorial (2) compared the current state of medicine to that of the medieval craft guilds. I would also make the comparison to labor unions at the height of their power. They had the ability to ensure consistent quality of workmanship and productivity from their members in exchange for their collective bargaining power. That gave the unions the ability to gain benefits for their members. When the quality of work fell and costs exceeded what could be obtained elsewhere, the power of the unions abated.
The College holds an advantage, being the second largest physician organization in the country, and its academic tradition and political influence make it a leader. But it may seem self-serving to those outside the medical profession if a very thoughtful position paper fails to include changes in physician behavior while recommending changes by patients, payers, and employers. As a profession, we need to work collectively to reduce wasteful and inefficient practices. Otherwise, we will face continued pressure from outside the profession.
Thomas James III, MD Humana Louisville, KY 40202
Potential Financial Conflicts of Interest: Employment: Humana.
TO THE EDITOR:
The single biggest issue in the quality of health care is the failure to provide adequate time for caregivers to spend with patients (and even with colleagues). Time for quality history assessment, thorough examinations, and careful formulation of diagnosis and treatment plans is not being reimbursed adequately.
Single-payer health insurance makes great sense, and there must also be a shift in reimbursement away from testing and procedures toward adequate time for physicians and nurses to form the relationships with patients that are the essence of health care that heals. In Letters www.annals.org1994, the Pew-Fetzer Task Force report (1) clearly articulated the need for healing relationships as the foundation for quality health care.
Healing relationships require conscious focus on adequate time, not just on standards, rules, and regulations. We must address the issue of time as a necessary component of healing relationships and we must foster time spent between colleagues sharing knowledge, expertise, intuition, and support for the difficult but vital work of health care. 
Harvey S. Zarren, MD

IN RESPONSE:
Everyone who wrote a letter raised important points that should be considered by public policymakers for achieving universal health insurance coverage. The American College of Physicians identified 2 pathways for consideration: a single-payer model or a pluralistic model with legal guarantees for coverage and subsidies for those who cannot afford it. The College did not recommend one pathway over the other-it noted the advantages and disadvantages of each approach. It examined the U.S. health care system and those of 12 other countries, determined what lessons could be learned, and made recommendations for consideration to ensure that all people in the United States have equitable access to appropriate health care without unreasonable financial barriers. Although we can learn much from other health care systems, the College recognizes that our political and social culture, demographic characteristics, and form of government will shape any solution for the United States.
Overhauling our health care system will be an extremely complicated matter and should involve a thorough examination of not only the many issues raised in this position paper, but other issues that, although important, would require separate in-depth study. Several of the ideas presented in these letters have been addressed in earlier position papers from the College.
Dr. Cavale and Dr. Leff raise the issue of malpractice insurance and fear of litigation, which we did not address because differences among legal systems make it extremely difficult to develop meaningful comparisons across nations. The College supports further research and analysis of the impact of the U.S. tort system on health care, as well as alternative models in other health systems. Likewise, comprehensive study is needed concerning the widely differing pharmaceutical costs among countries and the impact on health care systems of differences in the organization and financing of medical education and training.
Drs. R.L. Cruess and S.R. Cruess raise another issue to be explored if the United States were to adopt a single-payer system: A structure would be needed for negotiating physician payments. As they correctly point out, there currently is no legal structure in the United States for collective bargaining on behalf of self-employed physicians. The College has recommended legal reforms to allow physicians to bargain collectively with payers but has also cautioned that physicians may not ethically strike or withhold services from patients (1) .
The College agrees with Dr. James that physicians need to be accountable. The patient-centered medical home is one model for improving quality and efficiency that would require qualified practices to report regularly and in a transparent manner on measures of quality, efficiency, and patient satisfaction. More detailed recommendations from the College are in separate position papers on linking physician payment to quality (2) and shifting incentives away from volume-based rewards toward ones that create incentives for care coordination, prevention, and improvements in quality (3). More must be done, however, to improve accountability among all who are involved in patient care.
Dr. Zarren raises the issues of lack of adequate time for physicians to see and treat patients. This topic also was discussed at length in another College position paper (4).
We limited our study to analysis of the U.S. health care system and systems in 12 other industrialized countries that are representative of different approaches to achieving universal coverage. We did not include the MHS TRICARE plan, which has a unique mission in providing care to military personnel and their families, but we agree that there is much to learn from it.
The paper that appeared in Annals was an abridged version of the full position paper approved by the American College of Physicians' Board of Regents on 27 October 2007. The full text is available at www.acponline.org/advocacy/where_we_stand/access/hcs .pdf.
We describe a family in which 2 counteracting mutations in the apolipoprotein B gene (APOB) were transmitted and resulted in a clinically normolipidemic phenotype.
Case Report: A 38-year-old man (index patient [patient II-4 in Figure] ) and 2 of his children (patients III-1 and III-3) had elevated levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B100 (apoB) caused by a point mutation (R3500Q) in APOB, underlying familial defective apolipoprotein B (FDB). In contrast, his spouse (patient II-3) and a third child (patient III-4) had substantially low levels of LDL cholesterol, apolipoprotein B (apoB), and triglycerides caused by another mutation (11712delC) in APOB, leading to familial hypobetalipoproteinemia (FHBL) (1) . A fourth child (patient III-2) had a normal lipoprotein profile. DNA analysis revealed that this child carried the R3500Q mutation on 1 allele and the 11712delC mutation on the other allele and, therefore, could have FDB as well as FHBL. We determined levels of liver enzymes and fat-soluble vitamins. We performed ultrasonography of the liver in the individuals with FHBL and found no signs of hepatic steatosis. All family members received lifestyle and dietary advice and cholesterol-lowering medication where appropriate.
Discussion: We describe a family in which 2 hereditary disorders of lipoprotein metabolism coincide: underlying hyper-as well as hypocholesterolemia. Of interest, the offspring (patient III-2) who carried the 2 APOB mutations and was affected by both FDB and FHBL exhibited normal levels of LDL cholesterol and apoB, demonstrating that these 2 mutations neutralize each others' consequences for lipoprotein metabolism.
Familial defective apolipoprotein B is an autosomal dominant disorder caused by mutations in the ligand-binding domain (exon 26) of the APOB gene, localized on chromosome 2, that result in defective binding of LDL particles to the intact LDL receptor. Clinically, heterozygous FDB is characterized by elevated levels of total cholesterol and LDL cholesterol, the occurrence of tendon xanthomas, and premature coronary artery disease. The main treatment target focuses on preventing coronary artery disease by lowering LDL cholesterol levels. Familial hypobetalipoproteinemia is an autosomal dominant disorder caused by mutations in APOB that lead to premature stop codons or truncation of the apoB protein. In contrast to FDB, heterozygous FHBL is characterized by levels of LDL cholesterol and apoB below the fifth percentile for sex and age. Most of the reported mutations prevent the translation into a full-length apoB protein, which reduces the assembly of very-low-density lipoprotein cholesterol in the liver or chylomicrons in the intestine (2) . Heterozygous patients are mostly asymptomatic, but they are at risk for nonalcoholic fatty liver disease because of the accumulation of triglycerides in the liver. Liver fat percentages can be 3-to 5-fold greater (3). The long-term effects of hepatosteatosis in this population are not yet clear. The absorption of fat-soluble vitamins may be disturbed. If fatty liver disease in patients with FHBL is diagnosed early, patients can prevent related sequelae by adhering to a proper diet, making appropriate lifestyle adjustments, and taking fat-soluble vitamin supplements. No drug treatment for fatty liver disease is available. Conversely, as a result of the extremely low levels of circulating apoB in FHBL, patients show decreased vascular wall stiffness. Because arterial wall stiffness might predict future cardiovascular events, the risk for coronary artery disease is likely to be low in such individuals (4).
In conclusion, the extremely rare combination of both FDB and FHBL in 1 patient resulted in normal levels of total cholesterol and LDL cholesterol. The principle of reducing LDL cholesterol and apoB levels by inhibition of the assembly of very-low-density lipoprotein particles is the rationale of a recently developed cholesterollowering strategy. This strategy consists of the administration of antisense apoB messenger RNA and has already been demonstrated to reduce levels of LDL cholesterol and apoB in healthy volunteers (5) .
Conclusion: Mutations in the APOB gene that disrupt very-lowdensity lipoprotein particle secretion by the liver can neutralize the consequences of delayed liver uptake of LDL particles. The findings in this family offer hope for the future of inhibition of early-stage apoB synthesis.
Should Systematic Reviewers Search for Randomized, Controlled Trials Published as Letters?
Background: A report by Deeks and Altman (1) found randomized, controlled trials (RCTs) published as letters to be incompletely reported and noncompliant with the Consolidated Standards of Reporting Trials (CONSORT). The authors recommended that journals reexamine their policies of publishing RCTs as short reports.
We examined RCTs published as letters before and after these recommendations. Our interest stems from our involvement in information retrieval for systematic reviews. A rigorous search strategy is a key component in identifying evidence (2) , because an inadequate search strategy could result in missed studies and misleading conclusions. Yet, these searches often exclude certain publication types, such as letters and editorials (3). This is thought to improve the search precision and reduce reviewer burden by eliminating irrelevant citations.
Objective: To determine whether RCTs would be missed by excluding letters from the search strategy.
Methods: We searched the MEDLINE database for citations with publication type Randomized Controlled Trial (RCT.pt) and the publication type Letter, but not the publication type Comment. We retrieved a total of 2066 letters tagged as publication type Randomized Controlled Trial. We selected a random sample of 200 citations and evaluated them to confirm their study design. After exclusion of non-English-language records (n ϭ 8), we screened a total of 192 letters. Two pairs of reviewers independently assessed each letter to confirm whether it met specified methodological criteria, such as presence of an intervention, at least 1 control group, and random allocation. Disagreements were resolved by consensus.
Results: After screening, we determined that a total of 157 (81.8%) letters were reports of RCTs. We found that letters tagged and determined as RCTs were more often published in premier clinical journals (MEDLINE's "Core Clinical Journal" set). The proportion of Core Clinical Journals (Abridged Index Medicus) dropped substantially from 58.3% before 1998 to 26.2% after 1998 (chisquare, 15.48; P Ͻ 0.001) (Table) .
Most of the trials reported clinical characteristics of trial groups (66.9%) and presented extractable outcome data (98.7%), essential for knowledge synthesis. Blinding of participants and investigators was reported in 42.7% of trials, whereas 52.2% reported on harms from the tested treatment. The importance of negative results in reducing bias is well known (4), and 17.2% of RCT letters reported negative results for the treatment being tested.
Citation rate is an important indicator of an article's influence in the research community. All letters from our sample that were indexed by the Institute for Scientific Information (n ϭ 141) were cited at least once (maximum, 139 citations), with a median of 5 citations (interquartile range, 2 to 10 citations). Thus, RCTs published as letters are, like other RCTs (5), influential.
Discussion: Although some high-impact journals seem to have changed their editorial practices because of the publication of the Deeks and Altman article (1), some RCTs are still published as letters. The partial uptake of these recommendations is an example of incomplete knowledge translation. Many systematic reviewers may assume that this practice has stopped and may inadvertently miss potentially eligible and informative reports by excluding letters from their search.
In establishing any evidence base, study design should be given precedence over publication format. Reviewers undertaking systematic reviews of RCTs should not exclude all letters, but rather use the logical construction NOT (letter.pt. NOT randomized controlled trial.pt.) when excluding letters from a MEDLINE search.
Hopewell and colleagues (6) have suggested a modified version of CONSORT to optimize reporting of conference abstracts. Such a standard could usefully apply to RCTs published as letters, and when space constraints prevent adequate reporting, authors should consider publishing results as a full article instead. 
Alla E. Iansavichene, MLIS
